A patient with a history of asthma is experiencing an exacerbation characterized by chest tightness, wheezing, and an elevated eosinophil count. Despite receiving nebulized Albuterol, symptoms persist. The healthcare team is considering adding a systemic corticosteroid to the treatment plan. Which of the following is the primary reason for adding corticosteroids in this scenario?

B) To address underlying inflammation contributing to the exacerbation

A) To immediately reduce bronchoconstriction

B) To address underlying inflammation contributing to the exacerbation

C) To prevent future episodes of asthma exacerbation

D) To directly combat potential bacterial infection

A patient with a known history of asthma presents to the emergency department experiencing an exacerbation, which is partially relieved by nebulized Albuterol. Despite improved oxygen saturation, the patient continues to experience chest tightness and wheezing. With an elevated eosinophil count and mild hyperinflation shown on a chest X-ray, what is the most appropriate next step in the management of this patient?

B) Initiate systemic corticosteroids to reduce airway inflammation

A) Administer an antihistamine to address the allergic component

B) Initiate systemic corticosteroids to reduce airway inflammation

C) Increase the frequency of Albuterol nebulization

D) Begin antibiotic therapy to prevent a secondary infection

A patient experiencing an acute asthma exacerbation is showing signs of increased respiratory distress, including a respiratory rate of 26 breaths per minute, oxygen saturation of 91%, and diminished breath sounds with wheezing and crackles. Which nursing intervention should be prioritized to address the immediate respiratory needs of this patient?

C) Administer an additional dose of nebulized bronchodilator to relieve bronchospasm

A) Administer a systemic corticosteroid to reduce airway inflammation

B) Prepare the patient for intubation due to potential respiratory failure

C) Administer an additional dose of nebulized bronchodilator to relieve bronchospasm

D) Arrange for a chest X-ray to assess for possible pneumothorax

A patient experiencing an acute asthma exacerbation is showing signs of increased respiratory distress, including a respiratory rate of 26 breaths per minute, oxygen saturation of 91%, and diminished breath sounds with wheezing and crackles. After administering a systemic corticosteroid and a nebulized bronchodilator, what should be the next priority nursing action?

B) Obtain an arterial blood gas analysis to evaluate respiratory status

A) Prepare the patient for intubation and mechanical ventilation

B) Obtain an arterial blood gas analysis to evaluate respiratory status

C) Administer an antibiotic to address potential secondary bacterial infection

D) Educate the patient on breathing techniques to reduce anxiety

A patient with asthma exacerbation is experiencing mild hypoxemia and respiratory acidosis despite treatment with prednisone and nebulized bronchodilators. The healthcare team is considering the initiation of non-invasive positive pressure ventilation (NIPPV). What is the primary goal of using NIPPV in this patient?

B) To decrease the partial pressure of carbon dioxide and improve oxygenation.

A) To increase the patient's tidal volume and relieve chest tightness.

B) To decrease the partial pressure of carbon dioxide and improve oxygenation.

C) To completely replace the need for systemic corticosteroids.

D) To eliminate the need for further bronchodilator therapy.

A patient with asthma exacerbation has been treated with prednisone and nebulized bronchodilators. Despite treatment, the patient's ABG results show PaO2 of 68 mmHg, PaCO2 of 48 mmHg, and pH of 7.33, indicating respiratory acidosis. Which intervention should the nurse anticipate to best address the underlying issue?

B) Administering an additional dose of systemic corticosteroids

C) Increasing the frequency of nebulized bronchodilators

D) Providing supplemental oxygen via nasal cannula

A patient with a history of asthma is currently receiving non-invasive positive pressure ventilation (NIPPV) and continues to experience chest tightness and anxiety. A chest X-ray reveals atelectasis in the right lower lobe. What is the most appropriate nursing intervention to address the atelectasis while continuing to manage the patient's asthma symptoms?

B) Encourage the use of incentive spirometry every hour while awake.

A) Increase the NIPPV pressure settings to reduce atelectasis.

B) Encourage the use of incentive spirometry every hour while awake.

C) Administer an additional dose of bronchodilator via nebulizer.

D) Request an immediate consultation with a pulmonologist.

A patient with asthma exacerbation is receiving non-invasive positive pressure ventilation (NIPPV) and shows improvement in respiratory rate and oxygen saturation. However, a chest X-ray reveals a small area of atelectasis in the right lower lobe. Which nursing intervention is most appropriate to address the atelectasis and improve the patient's respiratory status?

B) Encourage the use of incentive spirometry to expand the affected lung area.

A) Increase the oxygen flow rate to improve oxygen saturation.

B) Encourage the use of incentive spirometry to expand the affected lung area.

C) Administer an additional dose of bronchodilator to reduce bronchospasm.

D) Position the patient in the prone position to enhance lung expansion.

A patient with a history of atelectasis and asthma is experiencing increased respiratory distress and diminished breath sounds in the right lower lung field, along with widespread wheezing. After administering a short-acting beta-agonist via a nebulizer, which intervention should the nurse prioritize next to optimize the patient's respiratory status?

B) Adjust the NIPPV settings to improve alveolar recruitment and oxygenation.

A) Increase the frequency of corticosteroid administration to reduce inflammation.

B) Adjust the NIPPV settings to improve alveolar recruitment and oxygenation.

C) Initiate continuous pulse oximetry monitoring to assess for hypoxemia.

D) Encourage continued use of incentive spirometry to prevent further atelectasis.

A patient with a history of asthma is experiencing increased respiratory distress, evidenced by decreased oxygen saturation and wheezing. After administering a short-acting beta-agonist via nebulizer, what is the nurse's priority action to ensure effective management of the patient's condition?

B) Reassess the patient's breath sounds and oxygen saturation to evaluate the response to the bronchodilator.

A) Administer a dose of oral corticosteroids immediately to reduce inflammation.

B) Reassess the patient's breath sounds and oxygen saturation to evaluate the response to the bronchodilator.

C) Increase the frequency of incentive spirometry to promote lung expansion.

D) Prepare to intubate the patient due to impending respiratory failure.

asthma attack - Nursing Case Study

Pathophysiology

• Primary mechanism: Bronchoconstriction occurs due to hyperresponsiveness of the smooth muscles in the airways, triggered by allergens or irritants, leading to narrowed air passages and difficulty in breathing.

• Secondary mechanism: Inflammation of the airway walls results in edema and increased mucus production, further obstructing airflow and exacerbating symptoms such as wheezing and coughing.

• Key complication: If untreated, prolonged bronchoconstriction and inflammation can lead to airway remodeling, causing persistent airflow limitation and increased frequency of asthma attacks.

Patient Profile

Demographics:

35-year-old female, office administrator

History:

• Key past medical history: Asthma diagnosed at age 22, seasonal allergies

• Current medications: Albuterol inhaler as needed, Fluticasone inhaler daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and wheezing

• Key symptoms: Persistent cough, chest tightness, difficulty breathing

• Vital signs: Temperature 98.9°F, Heart rate 112 bpm, Respiratory rate 24 breaths per minute, Blood pressure 138/88 mmHg, Oxygen saturation 90% on room air

Section 1

As the healthcare team initiates treatment, the patient is placed on supplemental oxygen, and a nebulized Albuterol treatment is administered to address the bronchoconstriction. Following this initial intervention, her oxygen saturation improves to 94%, and her respiratory rate decreases to 20 breaths per minute. However, the patient continues to experience chest tightness and wheezing, although her cough is slightly less frequent. During the physical assessment, auscultation reveals diminished breath sounds in the lower lung fields with persistent expiratory wheezes, indicating ongoing airflow obstruction. Given these findings and the patient's history of asthma, the team considers the possibility of an exacerbation potentially complicated by an underlying infection or other trigger.

Laboratory studies and a chest X-ray are ordered to further evaluate the patient's condition. The complete blood count reveals a mild leukocytosis with an elevated eosinophil count, suggesting an allergic component to the exacerbation. Meanwhile, the chest X-ray shows no signs of pneumonia but does indicate mild hyperinflation of the lungs, consistent with an acute asthma exacerbation. The patient's heart rate remains elevated at 108 bpm, and blood pressure is stable at 136/86 mmHg, suggesting that the sympathetic response to asthma has not fully resolved. The team considers adding a systemic corticosteroid to the treatment regimen to address the inflammation and recommends the continuation of bronchodilator therapy. As the case unfolds, careful monitoring for potential new complications, such as the development of a secondary infection or worsening bronchospasm, becomes crucial in guiding further management decisions.

Section 2

As the healthcare team closely monitors the patient, they observe a change in her status that warrants immediate attention. Despite the initial improvement with Albuterol and supplemental oxygen, the patient begins to display signs of increased respiratory distress. Her respiratory rate climbs to 26 breaths per minute, and her oxygen saturation drops slightly to 91%, causing concern among the team. The patient reports increased chest tightness and a sensation of not being able to catch her breath, which heightens her anxiety and further complicates her breathing pattern. On auscultation, breath sounds are now markedly diminished in both upper and lower lung fields, with persistent wheezing and newly apparent crackles in the right lower lobe, suggesting possible fluid accumulation or atelectasis.

In response to these changes, the team swiftly reevaluates her treatment plan. Given the patient's persistent symptoms and lab results indicating an allergic component, a systemic corticosteroid, such as prednisone, is administered to mitigate airway inflammation more effectively. Additionally, another dose of nebulized bronchodilator is given to provide immediate relief of bronchospasm. The team also considers obtaining arterial blood gases to assess the severity of hypoxemia and the potential development of respiratory acidosis, which could indicate worsening respiratory function.

Amidst these developments, the team remains vigilant for new complications, such as the potential for a secondary bacterial infection given the crackles heard in the lung fields, or the risk of pneumothorax due to hyperinflation and increased work of breathing. These considerations require ongoing assessment and appropriate interventions to prevent deterioration of the patient's condition. The situation underscores the necessity for dynamic clinical reasoning and adaptable management strategies in the context of an acute asthma exacerbation, as the team continues to tailor their approach based on the patient's evolving clinical picture.

Section 3

As the healthcare team reassesses the patient's condition following the administration of prednisone and an additional dose of nebulized bronchodilator, they closely monitor for any changes in her respiratory status. Initially, there is a slight improvement in her respiratory rate, which decreases to 22 breaths per minute, while her oxygen saturation stabilizes at 93%. However, the patient's chest tightness persists, and she continues to express difficulty in breathing, maintaining a heightened level of anxiety. Recognizing the importance of thorough evaluation, the team decides to perform arterial blood gas analysis to gain deeper insight into her respiratory function.

The arterial blood gas results reveal a concerning picture: the patient is experiencing mild hypoxemia with a partial pressure of oxygen (PaO2) of 68 mmHg and a partial pressure of carbon dioxide (PaCO2) elevated at 48 mmHg, indicating the onset of respiratory acidosis. The pH is slightly lowered at 7.33, reflecting the body's struggle to compensate for the impaired gas exchange. These findings suggest that despite the interventions, the patient's respiratory function is still compromised, necessitating a reevaluation of the treatment plan.

In light of the new diagnostic results, the healthcare team discusses the possibility of initiating non-invasive positive pressure ventilation (NIPPV) to support the patient's breathing and improve alveolar ventilation. Concurrently, they consider the necessity of ordering a chest X-ray to further investigate the presence of crackles in the right lower lobe, which could indicate atelectasis or a secondary bacterial infection. These steps are critical to prevent further deterioration and align with the goal of optimizing the patient's respiratory status. The team remains attentive to the potential for new complications and continues to adapt their management strategy, emphasizing the importance of dynamic clinical reasoning in managing complex asthma exacerbations.

Section 4

As the healthcare team implements the plan to initiate non-invasive positive pressure ventilation (NIPPV), they closely monitor the patient's response. Initially, the application of NIPPV leads to a noticeable improvement in the patient's work of breathing. Her respiratory rate decreases further to 18 breaths per minute, and there is a modest increase in oxygen saturation, now holding steady at 95%. Despite these positive changes, the patient still reports significant chest tightness and anxiety, which suggests that her respiratory muscles are fatigued from the prolonged effort of breathing against obstructed airways.

During this time, the results of the chest X-ray return, revealing a small area of atelectasis in the right lower lobe, which is likely contributing to the patient's ongoing hypoxemia and respiratory distress. There is no clear evidence of a bacterial infection, as the white blood cell count remains within normal limits and the patient is afebrile. This finding prompts the team to consider the addition of incentive spirometry and other physiotherapy measures to help expand the affected lung area and improve ventilation.

The team remains vigilant for any new complications, aware that the presence of atelectasis can predispose the patient to secondary infections if not addressed promptly. They also review the patient's medication regimen, ensuring that she continues to receive bronchodilators and corticosteroids to reduce inflammation and bronchospasm. The collaborative approach among the healthcare team members, along with the integration of dynamic clinical reasoning, underscores the complexity of managing this asthma exacerbation while striving to prevent further deterioration and promote recovery.

Section 5

As the healthcare team continues to monitor the patient, they observe a change in her status that necessitates prompt attention. Approximately two hours after the initiation of non-invasive positive pressure ventilation and physiotherapy measures, the patient's oxygen saturation unexpectedly drops to 90%, and her respiratory rate begins to climb again, reaching 24 breaths per minute. She expresses increased difficulty with breathing and a renewed sense of panic. Upon auscultation, the nurse notes diminished breath sounds in the right lower lung field, consistent with the earlier finding of atelectasis, but now also hears faint wheezing throughout both lung fields, indicating widespread bronchoconstriction.

Recognizing the potential for worsening bronchospasm, the team reassesses her medication regimen. Despite regular administration of bronchodilators, it seems the patient's airways remain highly reactive. The decision is made to administer an additional dose of a short-acting beta-agonist via a nebulizer, closely monitoring her response. Concurrently, they consider increasing the frequency of corticosteroid administration to address persistent inflammation. The team discusses the possibility of adjusting the NIPPV settings to optimize alveolar recruitment and enhance oxygen delivery, while also emphasizing the importance of continued incentive spirometry to combat atelectasis.

These developments highlight the complexity of her clinical picture, requiring thoughtful integration of the clinical data to guide further interventions. The team remains vigilant for any signs of new infections or complications, aware that the patient's prolonged respiratory distress and intermittent hypoxemia might compromise her overall condition. The next steps in her management will focus on stabilizing her respiratory status, preventing secondary complications, and ensuring effective communication among all members of the healthcare team to promote a coordinated approach to her care.